Become a Founding Member for $999 a year, locked for life

    Claim a seat
    MavenlyMavenly

    § Federal grant opportunity · PAR-28-022

    Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

    National Institutes of Health is accepting applications for Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required). The deadline is September 25, 2029 and the published award range is Award amount not published.

    Key facts

    Funder
    National Institutes of Health
    Application deadline
    September 25, 2029
    Award range
    Award amount not published
    Eligibility
    federally recognized native american tribal governments, other native american tribal organizations, public and indian housing authorities, state governments, county governments, public and state institutions of higher education, independent school districts, city or township governments, special district governments, small businesses, nonprofits non higher education without 501c3, for profit organizations other than small businesses, private institutions of higher education, nonprofits non higher education with 501c3, other
    Geography
    United States
    Focus areas
    Health
    Opportunity number
    PAR-28-022

    Program overview

    Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPOREs). Based on the proposed research, applications may be jointly funded with the National Institute of Dental and Craniofacial Research (NIDCR). This is a re-issuance of PAR-23-284 . The program will fund P50 SPORE grants to support state-of-the-art investigator-initiated translational research that will contribute to improved prevention, early detection, diagnosis, and treatment of an organ-specific cancer or a highly related group of cancers. The research supported through this program must be translational and be based on human biology research using cellular, molecular, structural, biochemical, and/or genetic experimental approaches. SPORE projects must reach a translational human endpoint within the project period of the grant.

    How to apply

    1. Confirm your organization meets the eligibility criteria above.
    2. Read the full funding opportunity announcement from National Institutes of Health.
    3. Draft your narrative against the funder's stated priorities and review criteria.
    4. Submit before September 25, 2029, allowing time for registration and validation.

    View the official funding announcement

    Find every grant your organization qualifies for

    Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.